Article
Histology-based molecular profiling improves mutation detection for advanced thyroid cancer.
Genes, chromosomes & cancer - 1 Aug 2021
Eszlinger Markus, Khalil Moosa, Gillmor Aaron Hill, Huang Helen, Stewardson Paul, McIntyre John B, Morrissy Sorana, Paschke Ralf
Abstract excerpt
Advanced cancers frequently show histologic and molecular intratumoral heterogeneity. Therefore, we comprehensively characterized advanced, metastatic, radioiodine-resistant (RAIR) thyroid carcinomas at the molecular level in the context of histologic heterogeneity with the aim to identify potentially actionable mutations that may guide the use of specific tyrosine kinase inhibitor (TKI) treatment. Whole exome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
